Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Charles A Baker. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Charles A Baker har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:REGN / Regeneron Pharmaceuticals, Inc. Director 7.439
US:PGNX / Progenics Pharmaceuticals, Inc. Director 10.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Charles A Baker. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Charles A Baker som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2018-01-03 2018-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7.439 7.439
2017-10-03 2017-09-29 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.000 0 -100,00
2017-10-03 2017-09-29 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.000 9.000 -18,18 450,00 -900.000 4.050.000
2017-10-03 2017-09-29 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 2.000 11.000 22,22 18,61 37.220 204.710
2017-01-05 2017-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7.830 7.830
2016-12-14 2016-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 2.000 -60,00
2016-12-14 2016-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 9.000 -2,17 394,33 -78.866 3.548.970
2016-12-14 2016-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -600 9.200 -6,12 393,64 -236.184 3.621.488
2016-12-14 2016-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -400 9.800 -3,92 392,41 -156.964 3.845.618
2016-12-14 2016-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.200 10.200 -10,53 391,36 -469.632 3.991.872
2016-12-14 2016-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -600 11.400 -5,00 390,67 -234.402 4.453.638
2016-12-14 2016-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3.000 12.000 33,33 18,61 55.830 223.320
2016-01-06 2016-01-04 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 9.212 9.212
2015-09-18 2015-09-17 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 5.000 -50,00
2015-09-18 2015-09-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -5.000 9.000 -35,71 550,00 -2.750.000 4.950.000
2015-09-18 2015-09-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.000 14.000 55,56 18,61 93.050 260.540
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 10.000 -33,33
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 9.000 -2,17 457,21 -91.442 4.114.890
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -700 9.200 -7,07 456,36 -319.452 4.198.512
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.536 9.900 -13,43 455,48 -699.617 4.509.252
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.999 11.436 -14,88 454,38 -908.306 5.196.290
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -265 13.435 -1,93 453,71 -120.233 6.095.594
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 13.700 -2,14 452,45 -135.735 6.198.565
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.000 14.000 55,56 18,61 93.050 260.540
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 10.838 10.838
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -15.000 0 -100,00
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 9.000 -1,10 313,40 -31.340 2.820.600
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -600 9.100 -6,19 312,29 -187.374 2.841.839
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.200 9.700 -11,01 311,46 -373.752 3.021.162
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -600 10.900 -5,22 310,80 -186.480 3.387.720
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -400 11.500 -3,36 308,25 -123.300 3.544.875
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 11.900 -2,46 307,65 -92.295 3.661.035
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 12.200 -1,61 305,25 -61.050 3.724.050
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 12.400 -2,36 304,42 -91.326 3.774.808
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 12.700 -2,31 303,64 -91.092 3.856.228
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 13.000 -0,76 302,90 -30.290 3.937.700
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -700 13.100 -5,07 301,12 -210.784 3.944.672
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -10.200 13.800 -42,50 300,09 -3.060.918 4.141.242
2014-03-25 2014-03-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 24.000 166,67 23,84 357.600 572.160
2014-01-06 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12.750 12.750
2014-01-06 2013-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -590 0 -100,00
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -15.000 0 -100,00
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -400 9.000 -4,26 319,13 -127.652 2.872.170
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -700 9.400 -6,93 318,27 -222.789 2.991.738
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -900 10.100 -8,18 317,48 -285.732 3.206.548
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.200 11.000 -9,84 316,54 -379.848 3.481.940
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -800 12.200 -6,15 315,51 -252.408 3.849.222
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.608 13.000 -16,71 314,31 -819.720 4.086.030
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.705 15.608 -19,18 313,47 -1.161.406 4.892.640
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.887 19.313 -16,75 312,53 -1.214.804 6.035.892
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 23.200 -1,28 311,59 -93.477 7.228.888
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 23.500 -0,42 309,73 -30.973 7.278.655
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 23.600 -0,42 308,91 -30.891 7.290.276
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 23.700 -1,25 302,46 -90.738 7.168.302
2013-10-02 2013-09-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 24.000 166,67 19,69 295.350 472.560
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -15.000 0 -100,00
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 9.000 -3,23 257,99 -77.397 2.321.910
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 9.300 -2,11 255,16 -51.032 2.372.988
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -756 9.500 -7,37 254,10 -192.100 2.413.950
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -908 10.256 -8,13 253,50 -230.178 2.599.896
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -4.748 11.164 -29,84 252,32 -1.198.015 2.816.900
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.938 15.912 -19,84 251,67 -991.076 4.004.573
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -4.150 19.850 -17,29 250,06 -1.037.749 4.963.691
2013-06-12 2013-06-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 24.000 166,67 15,80 237.000 379.200
2013-01-03 2013-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.100 0 -100,00
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.100 0 -100,00
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.200 1.100 -52,17
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.035 2.300 -68,64
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.565 7.335 -47,23
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.100 9.590 -10,29 171,45 -188.595 1.644.206
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.100 10.690 11,47 9,17 10.087 98.027
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.100 10.690 11,47 9,17 10.087 98.027
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.200 9.590 -11,12 172,65 -207.180 1.655.714
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.200 10.790 12,51 9,17 11.004 98.944
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -5.035 9.590 -34,43 173,63 -874.227 1.665.112
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.035 14.625 52,50 9,17 46.171 134.111
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -6.565 9.590 -40,64 174,46 -1.145.330 1.673.071
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 6.565 16.155 68,46 9,17 60.201 148.141
2012-11-27 2012-11-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.100 9.590 -10,29 175,14 -192.654 1.679.593
2012-09-06 2012-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -13.714 0 -100,00
2012-09-06 2012-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -13.714 9.590 -58,85 150,00 -2.057.100 1.438.500
2012-09-06 2012-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 13.714 23.304 143,00 15,01 205.847 349.793
2012-09-06 2012-09-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.286 13.714 -8,57
2012-09-06 2012-09-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.286 9.590 -11,82 150,00 -192.900 1.438.500
2012-09-06 2012-09-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.286 10.876 13,41 15,01 19.303 163.249
2012-06-14 2012-06-13 4 PGNX PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000 7,93 79.300 79.300
2012-04-19 2012-04-19 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -12.910 0 -100,00
2012-04-19 2012-04-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -12.910 9.590 -57,38 125,00 -1.613.750 1.198.750
2012-04-19 2012-04-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.910 22.500 134,62 18,80 242.708 423.000
2012-04-19 2012-04-17 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.090 12.910 -13,93
2012-04-19 2012-04-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.090 9.590 -17,89 125,00 -261.250 1.198.750
2012-04-19 2012-04-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 2.090 11.680 21,79 18,80 39.292 219.584
2012-01-04 2012-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.535 0 -100,00
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -715 1.535 -31,78
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.465 2.250 -39,43
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.968 3.715 -44,41
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.071 6.683 -23,66
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.246 8.754 -12,46
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.535 590 -72,24 15,49 -23.779 9.140
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.535 2.125 260,17 12,00 18.420 25.500
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -715 590 -54,79 15,43 -11.031 9.103
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 715 1.305 121,19 12,00 8.580 15.660
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.465 590 -71,29 15,40 -22.562 9.087
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.465 2.055 248,31 12,00 17.580 24.660
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.968 590 -83,42 15,30 -45.410 9.027
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 2.968 3.558 503,05 12,00 35.616 42.696
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.071 590 -77,83 15,25 -31.583 8.998
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 2.071 2.661 351,02 12,00 24.852 31.932
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.246 590 -67,86 15,24 -18.988 8.991
2006-02-03 2006-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.246 1.836 211,19 12,00 14.952 22.032
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -500 0 -100,00
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -200 500 -28,57
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.000 700 -58,82
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.000 1.700 -37,04
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -700 2.700 -20,59
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -600 3.400 -15,00
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -500 4.000 -11,11
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -500 4.500 -10,00
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -500 590 -45,87 14,71 -7.355 8.679
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 500 1.090 84,75 14,00 7.000 15.260
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 590 -25,32 14,73 -2.946 8.691
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 200 790 33,90 14,00 2.800 11.060
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.000 590 -62,89 14,76 -14.760 8.708
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.000 1.590 169,49 14,00 14.000 22.260
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.000 590 -62,89 14,80 -14.800 8.732
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.000 1.590 169,49 14,00 14.000 22.260
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -700 590 -54,26 14,83 -10.381 8.750
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 700 1.290 118,64 14,00 9.800 18.060
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -600 590 -50,42 14,84 -8.904 8.756
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 600 1.190 101,69 14,00 8.400 16.660
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -500 590 -45,87 14,85 -7.425 8.762
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 500 1.090 84,75 14,00 7.000 15.260
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -500 590 -45,87 14,90 -7.450 8.791
2004-02-04 2004-02-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 500 1.090 84,75 14,00 7.000 15.260
2004-01-06 2004-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)